Myriad Genetics Inc (MYGN)

R&D Expense Growth

-7.75%

Quarterly · Period ending:

MYGN logo

MYGN R&D Expense Growth

Latest reported-7.75%
MYGN Quarterly R&D Growth (QoQ) (0.00% → -7.75%)
High-resolution chart · PNG

MYGN r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-7.7491%
6.2745%
-9.5745%
10.1563%
-6.9091%
-14.5963%
12.9825%
5.1661%
8.8353%
18.5714%
-12.5%
13.2075%
-5.7778%
-3.8462%
14.1463%
0.9852%
-4.2453%
3.4146%
9.0426%
-3.5897%
-15.5844%
0%
-100%
1.1494%
-11.6751%
4.7872%
-11.7371%
1.9139%
-2.7907%
-4.0179%
6.1611%
19.209%
-4.3243%
10.119%
-5.618%
-5.3191%
6.8182%
-5.3763%
-4.1237%
-0.5128%
13.3721%
2.994%
-2.907%
-8.0214%
12.1574%
-4.7475%
-22.5898%
12.0127%
50.683%
-21.6091%
1.708%
15.239%
7.0715%
-3.4664%
23.7456%
-6.1265%
3.3268%
14.7418%
20.435%
-7.8648%
38.4581%
9.4386%
5.7272%
9.6897%
-10.7392%
16.3273%
-10.8703%
115.3256%
-307.4846%
-10.5353%
16.345%
-68.947%
77.2247%
14.1178%
4.9222%
-0.5731%
11.773%
-5.4353%
-6.0261%
8.4712%
10.5932%
15.4335%
3.0543%
15.2324%
3.121%
6.8335%
10.7676%
9.3969%
-3.1154%
7.1985%
-10.9141%
-2.9764%
20.9807%
-9.5351%
11.6207%
2.4813%
22.2085%
1.4812%
4.249%
13.9827%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.